Eswatini’s Cannabis Crossroads: Swazi Gold, Medical Ambition and the Persistent Shadow of Prohibition

Eswatini (formerly Swaziland) occupies a distinctive place in Southern Africa’s cannabis story. For decades it has been one of the region’s most significant traditional producers, famous for the resinous landrace known as Swazi Gold. At the same time it maintains some of the stricter formal prohibitions on recreational use while cautiously opening doors to licensed medical and industrial activity. The result is a country whose cultural and economic relationship with the plant runs far deeper than its statute book currently acknowledges.

This article examines the legal framework, the enduring informal economy, recent policy signals, cross-border dynamics with South Africa, and what Eswatini’s trajectory means for the wider regional conversation.

The Legal Baseline

Recreational cannabis remains illegal in Eswatini. The primary instruments are the Opium and Habit-Forming Drugs Act of 1922 (as amended) and related pharmacy legislation. Possession, cultivation, sale and use for non-medical purposes are criminal offences. Penalties can be severe, particularly for trafficking, with terms of imprisonment that can reach many years.

Enforcement is real. Royal Eswatini Police Service operations, supported at times by the Umbutfo Eswatini Defence Force, regularly target cultivation sites and cross-border consignments. Seizures of hundreds of kilograms are reported, and joint work with South African authorities at border posts such as Oshoek continues to intercept significant volumes moving toward the larger South African market.

At the same time, Eswatini has joined the cohort of African countries that have authorised licensed medical cannabis and, in principle, industrial hemp activity. The framework is narrower than South Africa’s private-use recognition and more tightly controlled than some of the early medical-export pioneers. Licensed cultivation exists, but the number of operators remains limited and the domestic patient-access pathway is not broadly developed.

Swazi Gold and the Informal Economy

Long before any medical licence was issued, Eswatini’s highlands and rural areas produced cannabis that earned a reputation across the region and beyond. “Swazi Gold” became shorthand for a particular quality of traditional flower — often grown in small plots by ordinary households, including many women who turned to the crop as one of the few reliable cash sources in an economy with high unemployment and limited formal opportunities.

This informal production has never disappeared. Poverty, limited alternative livelihoods, and proximity to South Africa’s large consumer market sustain it. Cross-border movement of cannabis from Eswatini into South Africa remains a persistent feature of regional enforcement statistics. For many rural growers the plant is not a lifestyle choice or a political statement; it is a pragmatic response to economic necessity.

The tension is obvious. On one side stands a criminal law that treats the activity as serious offending. On the other stands a social reality in which the crop supports households and forms part of local agricultural knowledge. Medical and industrial licensing has so far done little to bridge that gap for the majority of traditional producers.

Policy Signals and Economic Ambition

Like several of its neighbours, Eswatini has explored cannabis as a potential contributor to economic diversification. Official statements and legislative adjustments have opened limited space for medical cultivation and export-oriented activity. The logic is familiar: attract investment, create formal jobs, generate foreign exchange, and bring a portion of the existing cultivation under regulatory oversight.

Progress has been cautious. The absolute monarchy’s political structure, capacity constraints, and the need to remain aligned with international drug-control expectations all shape the pace. Unlike Lesotho, which moved early and relatively aggressively into medical licensing, or Zimbabwe, which developed a more detailed permit system, Eswatini’s formal sector remains small. The informal sector, by contrast, continues at scale.

Any serious attempt to expand the legal industry will eventually have to confront the question of inclusion. Will traditional growers be offered realistic pathways into the formal system, or will licensing remain accessible mainly to well-capitalised external or elite-linked operators? The answer will determine whether the policy shift reduces or simply relocates the existing grey-market economy.

The South African Relationship

Eswatini’s cannabis dynamics cannot be understood in isolation from South Africa. The two countries share a long border, deep economic integration, and a large volume of people and goods crossing daily. South Africa’s 2018 Constitutional Court recognition of private adult use, followed by the Cannabis for Private Purposes Act, created a legal asymmetry. Private cultivation and use became protected on one side of the border while remaining criminal on the other.

That asymmetry has practical consequences. It influences the direction of informal trade, the risk calculations of growers and transporters, and the enforcement priorities of both police services. Large seizures on the South African side frequently identify Eswatini as a source or transit point. At the same time, South African demand helps sustain the rural production that Eswatini’s own law continues to prohibit.

For regional policy coherence the situation is awkward. A country that has constitutionally protected private use sits beside a country that still treats the same private activity as criminal, while both participate in the same informal market. Harmonisation is unlikely in the short term; managed coexistence and improved cross-border cooperation on trafficking (as opposed to low-level possession) are more realistic near-term goals.

Comparative Regional Position

Within the Southern African cohort, Eswatini sits between the early medical movers (Lesotho, Zimbabwe) and the stricter prohibitionist hold-outs. It has acknowledged the economic potential of the plant at official level, yet it has not created the kind of broad licensing environment or patient-access system that would shift significant activity out of the shadows. Recreational reform of the South African type is not currently on the agenda.

The country’s experience illustrates a recurring regional pattern: governments are more comfortable with export-oriented, tightly controlled medical or industrial projects than with domestic adult-use frameworks or the formalisation of existing small-scale producers. The political and administrative comfort zone remains narrow even when the cultural and economic footprint of the plant is wide.

Looking Forward

Eswatini’s cannabis future will be shaped by several variables: the government’s willingness to expand and simplify licensing, the degree to which traditional growers are offered workable entry points, the evolution of enforcement practice, and the continued pull of the South African market. Climate, land availability and existing agronomic knowledge give the country natural advantages. Institutional design will decide whether those advantages translate into broad-based benefit or remain confined to a small formal enclave.

For South African readers the Eswatini case sharpens familiar questions. Cross-border flows will not disappear simply because one country has protected private use. Rural livelihoods linked to the plant will not automatically formalise when licensing regimes are designed primarily for export capital. And regional policy coherence will remain elusive for as long as neighbouring legal regimes pull in different directions.

Swazi Gold was never just a product. It was, and remains, a marker of rural ingenuity, economic necessity and cultural continuity. The statute book has not caught up with that reality. Whether it will do so in a way that includes the people who kept the plant alive is the central question Eswatini still has to answer.